Welcome to LookChem.com Sign In|Join Free
  • or
H-PHE-ARG-OH TRIFLUOROACETATE SALT, also known as L-phenylalanine-L-arginine dipeptide trifluoroacetate salt, is a synthetic dipeptide consisting of L-phenylalanine and L-arginine joined by a peptide linkage. It is a water-soluble, stable, and bioactive compound with potential applications in various industries.

1238-09-1

Post Buying Request

1238-09-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1238-09-1 Usage

Uses

Used in Pharmaceutical Industry:
H-PHE-ARG-OH TRIFLUOROACETATE SALT is used as a pharmaceutical candidate for its potential therapeutic effects. The dipeptide has been found to exhibit anti-inflammatory, antioxidant, and immunomodulatory properties, making it a promising agent for the treatment of various diseases, including inflammatory disorders, neurodegenerative diseases, and cancer.
Used in Cosmetic Industry:
In the cosmetic industry, H-PHE-ARG-OH TRIFLUOROACETATE SALT is used as an active ingredient for its skin-protecting and anti-aging properties. The dipeptide can help improve skin elasticity, reduce the appearance of fine lines and wrinkles, and protect the skin from environmental stressors, such as UV radiation and pollution.
Used in Food and Nutrition Industry:
H-PHE-ARG-OH TRIFLUOROACETATE SALT is used as a functional ingredient in food and nutrition products for its potential health benefits. The dipeptide can enhance protein synthesis, support muscle growth and recovery, and improve overall physical performance. It can also be used as a flavor enhancer and a natural preservative in various food products.
Used in Agricultural Industry:
In agriculture, H-PHE-ARG-OH TRIFLUOROACETATE SALT is used as a biostimulant to promote plant growth and improve crop yield. The dipeptide can enhance nutrient uptake, stimulate root development, and increase stress resistance in plants, leading to healthier and more productive crops.
Overall, H-PHE-ARG-OH TRIFLUOROACETATE SALT is a versatile and bioactive dipeptide with potential applications in various industries, including pharmaceutical, cosmetic, food and nutrition, and agricultural sectors. Its unique properties and benefits make it a valuable compound for research and development in these fields.

Check Digit Verification of cas no

The CAS Registry Mumber 1238-09-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,2,3 and 8 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1238-09:
(6*1)+(5*2)+(4*3)+(3*8)+(2*0)+(1*9)=61
61 % 10 = 1
So 1238-09-1 is a valid CAS Registry Number.
InChI:InChI=1/C15H23N5O3/c16-11(9-10-5-2-1-3-6-10)13(21)20-12(14(22)23)7-4-8-19-15(17)18/h1-3,5-6,11-12H,4,7-9,16H2,(H,20,21)(H,22,23)(H4,17,18,19)

1238-09-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name H-PHE-ARG-OH TRIFLUOROACETATE SALT

1.2 Other means of identification

Product number -
Other names L-Phe-L-Arg

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1238-09-1 SDS

1238-09-1Relevant academic research and scientific papers

The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme

Tzakos, Andreas G.,Naqvi, Nawazish,Comporozos, Konstantinos,Pierattelli, Roberta,Theodorou, Vassiliki,Husain, Ahsan,Gerothanassis, Ioannis P.

, p. 5084 - 5087 (2006)

Enzyme-inhibitor recognition is considered one of the most fundamental aspects in the area of drug discovery. However, the molecular mechanism of this recognition process (induced fit or prebinding and adaptive selection among multiple conformers) in several cases remains unexplored. In order to shed light toward this step of the recognition process in the case of human angiotensin I converting enzyme (hACE) and its inhibitor captopril, we have established a novel combinatorial approach exploiting solution NMR, flexible docking calculations, mutagenesis, and enzymatic studies. We provide evidence that an equimolar ratio of the cis and trans states of captopril exists in solution and that the enzyme selects only the trans state of the inhibitor that presents architectural and stereoelectronic complementarity with its substrate binding groove.

The solid phase synthesis of peptides containing an arginine residue with an unprotected guanidine group

Rubina,Bespalova,Bushuev

, p. 235 - 244 (2000)

A new variant of the solid phase synthesis of arginine-containing peptides was proposed. The conditions for the attachment to the Wang polymer of Nα-Fmoc-arginine containing a protonated guanidine group were found. We demonstrated that this attachment is accompanied by neither racemization nor the attachment of the second Arg residue. Side reactions involving the guanidine group of arginine were studied, and methods for their prevention were proposed. The comparison of the carbodiimide method with a 1-hydroxybenzotriazole additive and a modified method with the use of Kastro's reagent for the introduction of Nα-Fmoc-Arg residue with the unprotected guanidine group into the growing peptide chain demonstrated the advantages of the second method. Bradykinin and a peptide corresponding to the 584-591 sequence of the transmembrane gp41 from HIV-1 were synthesized by the method proposed here.

γ-Valerolactone (GVL): An eco-friendly anchoring solvent for solid-phase peptide synthesis

Al Musaimi, Othman,El-Faham, Ayman,Basso, Alessandra,de la Torre, Beatriz G.,Albericio, Fernando

, (2019/08/26)

Due to the hazardous nature of CH2Cl2, regulatory authorities have imposed restrictions to minimize or even stop its use. It has therefore become imperative to identify environmentally benign solvents to replace it. Here we report on a bio derived solvent, γ-valerolactone, for the incorporation of the first amino acid onto p-alkoxybenzyl alcohol resin in solid-phase peptide synthesis. Satisfactory loading values (by a spectrophotometric method) were achieved. Furthermore, racemization and dipeptide formation were also checked and found to be acceptable.

PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF

-

, (2011/10/31)

Conjugates and compounds for making conjugates which are PBD molecules linked via the N10 position are disclosed, along with the use of the conjugates for treating proliferative diseases, including cancer.

Trends in asymmetric Michael reactions catalysed by tripeptides in combination with an achiral additive in different solvents

Tsogoeva, Svetlana B.,Jagtap, Sunil B.,Ardemasova, Zoya A.,Kalikhevich, Victor N.

, p. 4014 - 4019 (2007/10/03)

The potential of tripeptides 3, 6 and 12 as chiral catalysts for asymmetric Michael addition reactions in the presence of an achiral additive has been tested in different solvents (CHCI3, acetone, DMF, DMSO and the room-temperature ionic liquid

Synthesis of Ethylamide of Cyclic Undecapeptide Corresponding to the 593 - 603 Sequence of Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type Two

Sidorova, M. V.,Kudryavtseva, E. V.,Molokoedov, A. S.,Ovchinnikov, M. V.,Bespalova, Zh. D.

, p. 582 - 589 (2007/10/03)

Ethylamide of cyclic disulfide of the HIV-2 peptide antigen corresponding to the 593 - 603 sequence of the gp41 protein was synthesized by conventional methods of peptide chemistry in solution.The absence of racemization during fragment condensation was s

Cardiac atrial peptides

-

, (2008/06/13)

A DNA fragment encoding at least part of the ANF protein has been molecularly cloned and its nucleotide sequence partially determined. The composition and sequence of a peptide containing 116 amino acids within the ANF gene have been determined. Biologically active subunit peptides have been identified.

ATRIOPEPTINS. I. SYNTHESIS OF C-TERMINAL FRAGMENTS

Ovchinnikov, Mikhail V.,Bespalova, Zhanna D.,Molokoedov, Aleksandr S.,Revenko, Inna V.,Sepetov, Nikolai F.,et al

, p. 772 - 783 (2007/10/02)

Peptides, corresponding to the C-terminal sequence in atriopeptins, have been synthesized using classical methods of peptide synthesis in solution and characterized by various physicochemical methods.The synthetic strategy and methods are discussed.

SYNTHESIS OF DINITROPHENYLTETRAPEPTIDES AS CHROMOPHORIC SUBSTRATES OF ENDOPROTEINASES

Kulikov, S. V.,Sokolova, N. Yu.,Rodin, S. V.,Samartsev, M. A.

, p. 469 - 475 (2007/10/02)

The synthesis has been performed of ten tetrapeptides of the general formula Dnp-Gly-Gly-X-Arg-OH, where X = Val, Phe, Abu, Asp(OBut), Asp, Met, D-Phe, Ser, Thr, or Trp.The synthesis was carried out with Dnp-Gly-Gly-Onp, activated esters of pro

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1238-09-1